Last reviewed · How we verify

Standard-of-Care Intravenous Antibiotics

Postgraduate Medical Institute, Lahore · FDA-approved active Small molecule

Standard-of-Care Intravenous Antibiotics is a Antibiotic (multiple classes) Small molecule drug developed by Postgraduate Medical Institute, Lahore. It is currently FDA-approved for Serious bacterial infections requiring intravenous therapy (e.g., sepsis, pneumonia, meningitis, endocarditis), Hospital-acquired infections, Surgical prophylaxis.

Standard-of-care intravenous antibiotics work by inhibiting bacterial protein synthesis, cell wall formation, or nucleic acid replication to kill or stop the growth of susceptible bacteria.

Standard-of-care intravenous antibiotics work by inhibiting bacterial protein synthesis, cell wall formation, or nucleic acid replication to kill or stop the growth of susceptible bacteria. Used for Serious bacterial infections requiring intravenous therapy (e.g., sepsis, pneumonia, meningitis, endocarditis), Hospital-acquired infections, Surgical prophylaxis.

At a glance

Generic nameStandard-of-Care Intravenous Antibiotics
SponsorPostgraduate Medical Institute, Lahore
Drug classAntibiotic (multiple classes)
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

This category encompasses multiple antibiotic classes (beta-lactams, aminoglycosides, fluoroquinolones, glycopeptides, etc.) that target different bacterial structures and processes. IV formulations provide high systemic concentrations for serious infections where oral bioavailability is insufficient or rapid onset is critical. The specific mechanism depends on the individual antibiotic agent used.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Standard-of-Care Intravenous Antibiotics

What is Standard-of-Care Intravenous Antibiotics?

Standard-of-Care Intravenous Antibiotics is a Antibiotic (multiple classes) drug developed by Postgraduate Medical Institute, Lahore, indicated for Serious bacterial infections requiring intravenous therapy (e.g., sepsis, pneumonia, meningitis, endocarditis), Hospital-acquired infections, Surgical prophylaxis.

How does Standard-of-Care Intravenous Antibiotics work?

Standard-of-care intravenous antibiotics work by inhibiting bacterial protein synthesis, cell wall formation, or nucleic acid replication to kill or stop the growth of susceptible bacteria.

What is Standard-of-Care Intravenous Antibiotics used for?

Standard-of-Care Intravenous Antibiotics is indicated for Serious bacterial infections requiring intravenous therapy (e.g., sepsis, pneumonia, meningitis, endocarditis), Hospital-acquired infections, Surgical prophylaxis.

Who makes Standard-of-Care Intravenous Antibiotics?

Standard-of-Care Intravenous Antibiotics is developed and marketed by Postgraduate Medical Institute, Lahore (see full Postgraduate Medical Institute, Lahore pipeline at /company/postgraduate-medical-institute-lahore).

What drug class is Standard-of-Care Intravenous Antibiotics in?

Standard-of-Care Intravenous Antibiotics belongs to the Antibiotic (multiple classes) class. See all Antibiotic (multiple classes) drugs at /class/antibiotic-multiple-classes.

What development phase is Standard-of-Care Intravenous Antibiotics in?

Standard-of-Care Intravenous Antibiotics is FDA-approved (marketed).

What are the side effects of Standard-of-Care Intravenous Antibiotics?

Common side effects of Standard-of-Care Intravenous Antibiotics include Hypersensitivity reactions (rash, anaphylaxis), Nephrotoxicity, Ototoxicity, Phlebitis at infusion site, Diarrhea/Clostridioides difficile infection, Hepatotoxicity.

Related